Large-scale testing (Phase 3)Study completedNCT01668966
What this trial is testing
A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 23